A heat-stable enterotoxin produced by Vibrio mimicus (VM-ST) was studied. VM-ST was purified from a culture supernatant of V. mimicus strain AQ-0915 by ammonium sulfate fractionation, hydroxyapatite treatment, ethanol extraction, column chromatography on both SP-Sephadex C-50 and DEAE-Sephadex A-25, and HPLC, and the recovery rate was about 15%. Purified VM-ST was heat-stable. VM-ST activity was cross-neutralized by anti-STh antiserum. The amino acid composition of the purified VM-ST was determined 17 amino acid residues in the following sequence: Ile-Asp-Cys-Cys-Glu-Ile-Cys-Cys-Asn-Pro-AlaCys-Phe-Gly-Cys-Leu-Asn. This composition and sequence were identical to those of V. cholerae non-O1-ST. These results clearly demonstrate the production of a characteristic VM-ST by V.
INTRODUCTION
Vibrio mimicus was proposed by Davis et al. [1] in 1981 as a new species similar to Vibrio cholerae non-O1, which does not ferment sucrose. This organism has been investigated as a causative agent of infectious diarrhoea [2, 3] . Production of various toxins by this organism such as cholera enterotoxin (CT)-like toxin [4] [5] [6] [7] and heat stable enterotoxin (ST)-like toxin [1, 7, 8] have been reported. However, previous reports [1, 7, 8] described ST-like toxin only with crude samples of V. mimicus and thus detailed properties of this toxin have not been clear.
In this study, we purified the ST-like toxin (VM-ST) of V. mimicus and found that it has an amino acid sequence identical to that of the V. cholerae non-O1 ST (NAG-ST) which was recently described by us [9, 10] .
MATERIALS AND METHODS

Strains and cultures
Strains were obtained from Osaka Airport Quarantine Station. Nine strains (AQ 0909-0913, 0915, 0916, 0932, 0936) were isolated from patients with traveller's diarrhoea and 8 strains (AQ 0918-0923, 0925, 0929) were isolated from imported frozen seafood. V. mimicus strains were maintained on semisolid nutrient agar tubes, and cultured in brain heart infusion broth supplemented with 0.5% NaC1 (BHI) at 37 °C with shaking as described previously [9] . Ten of 17 strains were positive in the suckling mouse assay. VM-ST was isolated and purified from a patient strain AQ-0915 which was positive in the suckling mouse assay but negative in the hemolytic activity assayed as previously described [12] .
Suckling mouse assay
Fluid accumulation (FA) test in the suckling mouse intestine was carried out as described by Dean et al. [12] .
Isolation of VM-ST
The toxin was isolated from the culture supernatant of V. mimicus AQ-0915 as described previously [9] . In brief, culture supernatants from cultures in BHI at 37 °C for 14 h were precipitated with ammonium sulfate (60%). After extensive dialysis against distilled water, samples were treated with hydroxyapatite (Nippon Chemical Co. Ltd., Tokyo), and then ethanol (-20°C) extraction was performed. Ethanol extracts were applied to a SP-Sephadex C-50 column (2 x 40 cm) equilibrated with distilled water, then eluted with distilled water and 0.05 M ammonium acetate (pH 6.6) as described before [9] . The mouse active fractions were then applied to a DEAE-Sephadex A-25 column (2 x 50 cm), eluted by a gradient of acetic acid (0-0.8 M). The active fractions were further purified on a Lichrosorb RP-8 column (reversed-phase high performance liquid chromatography (HPLC); Nippon Kemuko Co. Ltd.. Tokyo) equilibrated with 10% acetonitrile in 0.01 M ammonium acetate (pH 5.7). After washing with 10% acetonitrile in 0.01 M ammonium acetate. a linear gradient (2 ml/min) of 10-35% acetonitrile in 0.01 M ammonium acetate was applied. Purified toxin was obtained by HPLC rechromatography. Elution of the second HPLC was with 30 70% acetonitrile in 0,05% trifluoroacetic acid (TFA) (Inst. Peptide Co. Ltd., Osaka) (2 ml/min), instead of 0.01 M ammonium acetate.
Heat stable enterotoxin produced by enterotoxigenic E. coli (EC-STh) and anti EC-STh
EC-STh was purified from a strain of ETEC [13] and anti EC-STh antiserum was produced in rabbits as described previously [14] .
VM-ST or EC-STh adjusted to 20 mouse units (MU) per ml was neutralized with anti EC-STh antiserum by mixing 0.2 ml of serial two-fold diluted antiserum with an equal volume. One MU was defined as a minimum dose which causes an FA ratio of more than 0.090. Suckling mice were challenged with the mixture and remaining toxin activity was detected after 3 h incubation:
Heat stability
Purified VM-ST at a concentration of 20 or 40 MU per ml was heat treated at 60 °C for 30 rain. 100°C for 30 rain. or 121°C for 15 rain and the remaining activity was assayed in suckling mice.
Analysis of amino acid composition and ammo acid sequence determination
Purified VM-ST was hydrolyzed in 4 M methanesulfonic acid for 24 h at 110°C in a vacuum-sealed tube. The amino acid composition was determined by using a Hitachi type 835 analyzer [13] . Purified VM-ST was sequenced with an Applied Biosystems model 470A gas-phase sequenator (California), as described previously [101.
RESULTS
Six of 9 strains isolated from patients and four of 8 strains isolated from imported frozen food were positive in the suckling mouse assay. Among these ten positive strains, 3 and 2 strains, respectively, were positive for hemolytic activity. On the other hand, only one strain (AQ-0923) was positive for CT-like toxin by ELISA assay performed as described previously [11] . The strain AQ-0915, that was positive in the suckling mouse assay and negative in hemolytic activity, was used for isolation and purification of a ST-like toxin (VM-ST) VM-ST recovered from ammonium sulfate precipitation (60% saturation), hydroxyapatite treatment and ethanol extraction was applied to a SP-Sephadex C-50 column, and most activity was eluted with distilled water (Fig. 2) . The active fractions were further applied to a DEAE-Sep- VM-ST was eluted at 45% acetonitrile as a single peak (Fig. 3) . Table 1 summarizes the purification of VM-ST. The final recovery was about 157o and (Table 2 ). Even after heat treatment at 121°C for 15 rain. suckling mouse activity partially remained. Fig. 4 . suggesting that VM-ST has a partial immunological relationship to EC-STh. The amino acid composition of purified VM-ST was determined (Table 3) . VM-ST is composed of 17 amino acid residues, of which 6 were 1/2 Cys. This composition is identical to that of NAG-ST produced by V. cholerae non-O1 [9] , and very similar to EC-STs (STh [13] , STp [15] ) and Y-ST produced by Yersinia enterocolitica [16] . The amino acid sequence of VM-ST was also determined and found tO be identical to NAG-ST (Fig. 5 ).
Neutralization of VM-ST by anti EC-STh antiserum is demonstrated in
DISCUSSION
Pathogenesis of V. mimicus, a new species proposed by Davis et al. [1] in 1981, is poorly understood. Shandera et al. [3] analyzed 21 cases of V. mimicus infection, in which 19 displayed the major clinical symptoms of diarrhoea, stomach ache and vomiting. Most of these cases had ingested seafoods, especially raw oysters, prior to the appearance of symptoms.
Investigations on V. mimicus virulence factors have mainly been focused on CT-like enterotoxin [4] [5] [6] [7] . However, V. mimicus strains producing no CT-like enterotoxin have been frequently isolated from clinical specimens [6] [7] [8] . In these cases, toxin(s) other than CT-like toxin may be involved in the pathogenesis of these strains. Production of a ST-like toxin by V. mimicus strains, active in the suckling mouse assay has been suggested by several investigators [1, 7, 8] . However, the properties of this ST-like toxin could not be clarified until now because the toxin had not been purified.
In this study, we purified the ST-like toxin (VM-ST) from culture supernatants of a V. mimicus strain. Various features, including the amino acid sequence, clearly demonstrate that VM-ST is identical to the ST-like toxin (NAG-ST) recently described by us in V. cholerae non-O1 [9, 10] , and has similar (not identical) characteristics to STs (STh and STp) of ETEC. Although we purified VM-ST from only one strain of V. mimicus in this study, results of the suckling mouse assay reveal that V. mimicus strains frequently produce VM-ST, suggesting the importance of VM-ST in V. mimicus pathogenesis.
